| Title: |
Lenalidomide, Dexamethasone And Alemtuzumab Or Ofatumumab In High-Risk Chronic Lymphocytic Leukaemia: Final Results Of The NCRI CLL210 Trial |
| Authors: |
Pettitt, AR; Jackson, R; Cicconi, S; Polydoros, F; Yap, C; Dodd, J; Bickerstaff, M; Stackpoole, M; Khan, UT; Carruthers, S; Oates, M; Lin, K; Coupland, SE; Menon, G; Kalakonda, N; McCarthy, H; Bloor, A; Schuh, A; Duncombe, A; Dearden, C; Fegan, C; Kennedy, B; Walewska, R; Marshall, S; Fox, CP; Hillmen, P |
| Publisher Information: |
Ferrata Storti Foundation |
| Publication Year: |
2020 |
| Collection: |
White Rose Research Online (Universities of Leeds, Sheffield & York) |
| Document Type: |
article in journal/newspaper |
| File Description: |
text |
| Language: |
English |
| ISSN: |
0390-6078 |
| Relation: |
https://eprints.whiterose.ac.uk/id/eprint/157281/8/VoR%209646-Article%20Text-71176-2-10-20201118.pdf; Pettitt, AR, Jackson, R, Cicconi, S et al. (23 more authors) (2020) Lenalidomide, Dexamethasone And Alemtuzumab Or Ofatumumab In High-Risk Chronic Lymphocytic Leukaemia: Final Results Of The NCRI CLL210 Trial. Haematologica, 105 (12). pp. 2868-2871. ISSN: 0390-6078 |
| Availability: |
https://eprints.whiterose.ac.uk/id/eprint/157281/ |
| Rights: |
cc_by_nc_4 |
| Accession Number: |
edsbas.CD0F4BD5 |
| Database: |
BASE |